Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03809624
Title Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer (PDL1x41BB)
Acronym PDL1x41BB
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Inhibrx, Inc.
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST